Sector Gamma As Pfizer Inc Transaction History

Sector Gamma As

$256 Million
Q2 2024

A detailed history of Sector Gamma As transactions in Pfizer Inc stock. As of the latest transaction made, Sector Gamma As holds 895,000 shares of PFE stock, worth $24.6 Million. This represents 9.78% of its overall portfolio holdings.

Number of Shares

895,000

Previous 1,239,165 27.77%

Holding current value

$24.6 Million

Previous $34.4 Million 27.17%

% of portfolio

9.78%

Previous 10.14%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$25.26 - $29.6 $8.69 Million - $10.2 Million	-344,165 Reduced 27.77%	895,000 $25 Million
Q1 2024 May 08, 2024	BUY	$25.89 - $29.73 $3.77 Million - $4.33 Million	145,749 Added 13.33%	1,239,165 $34.4 Million
Q4 2023 Feb 05, 2024	BUY	$26.13 - $33.94 $28.6 Million - $37.1 Million	1,093,416 New	1,093,416 $31.5 Million
Q2 2022 Aug 05, 2022	SELL	$46.53 - $55.17 $1.38 Million - $1.64 Million	-29,738 Reduced 22.92%	100,000 $5.24 Million
Q1 2022 May 06, 2022	SELL	$45.75 - $56.69 $7.12 Million - $8.82 Million	-155,665 Reduced 54.54%	129,738 $6.72 Million
Q4 2021 Feb 08, 2022	SELL	$41.32 - $61.25 $15.1 Million - $22.4 Million	-366,197 Reduced 56.2%	285,403 $16.9 Million
Q3 2021 Oct 29, 2021	SELL	$39.25 - $50.42 $19.2 Million - $24.6 Million	-488,385 Reduced 42.84%	651,600 $28 Million
Q2 2021 Aug 04, 2021	SELL	$35.91 - $40.68 $8.11 Million - $9.18 Million	-225,778 Reduced 16.53%	1,139,985 $44.6 Million
Q1 2021 May 10, 2021	BUY	$33.49 - $37.77 $25.9 Million - $29.2 Million	772,513 Added 130.22%	1,365,763 $49.5 Million
Q4 2020 Feb 10, 2021	BUY	$33.47 - $42.56 $19.9 Million - $25.2 Million	593,250 New	593,250 $21.8 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sector Gamma As, based on Form 13F filings with the SEC.

News

Stay updated on Sector Gamma As with notifications on news.

Account